Despite some recent setbacks to its sickle cell disease (SCD) pipeline, Pfizer is plowing ahead in improving education around ...

You might have wondered why some people with sickle cell disease seem to live relatively normal lives while others spend half ...

The team responsible for updating the CDC’s “contraception bible,” which advises doctors on birth control safety, was ...

Sickle Cell Disease is the most common inherited blood disorder in the United States, affecting the lives of 100,000 people, ...

Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by ...

Sickle cell retinopathy in patients with sickle trait. Eye 1995;9:589–93. Article Google Scholar Goldberg MF . Sickle cell retinopathy. In: Tasman W, Jaeger EA, editors. Duane's clinical ...

Even if children with sickle cell disease appear asymptomatic, it's still crucial to provide proper care, says columnist.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

The evolutionary link between sickle-cell trait and malaria resistance showed ... such as numerous diarrheal diseases, yellow fever, and Lassa hemorrhagic fever. Today, with access to heretofore ...

For columnist Mary Shaniqua, who tracks her health closely, not being able to discern the causes of a sickle cell crisis is ...

Novartis has said it is “disappointed” that the EMA’s Human Medicines Committee has recommended revoking the conditional EU approval for sickle cell disease (SCD) therapy Adakveo ...